Brucella Melitensis UGPase Inhibits the Activation of NF-κB by Modulating the Ubiquitination of NEMO

Overview

Journal BMC Vet Res

Publisher Biomed Central

Specialty Veterinary Medicine

Date 2021 Aug 31

PMID 34461896

Citations 1

Authors

Yucheng Zhou

Zhaoyang Bu

Jing Qian

Yuening Cheng

Lianjiang Qiao

Sen Yang

Shipeng Cheng

Xinglong Wang

Linzhu Ren

Yanling Yang

Affiliations

Soon will be listed here.

Abstract

Background: UTP-glucose-1-phosphoryl transferase (UGPase) catalyzes the synthesis of UDP-glucose, which is essential for generating the glycogen needed for the synthesis of bacterial lipopolysaccharide (LPS) and capsular polysaccharide, which play important roles in bacterial virulence. However, the molecular function of UGPase in Brucella is still unknown.

Results: In this study, the ubiquitination modification of host immune-related protein in cells infected with UGPase-deleted or wild-type Brucella was analyzed using ubiquitination proteomics technology. The ubiquitination modification level and type of NF-κB Essential Modulator (NEMO or Ikbkg), a molecule necessary for NF-κB signal activation, was evaluated using Coimmunoprecipitation, Western blot, and dual-Luciferase Assay. We found 80 ubiquitin proteins were upregulated and 203 ubiquitin proteins were downregulated in cells infected with B. melitensis 16 M compared with those of B. melitensis UGPase-deleted strain (16 M-UGPase). Moreover, the ubiquitin-modified proteins were mostly enriched in the categories of regulation of kinase/NF-κB signaling and response to a bacterium, suggesting Brucella UGPase inhibits ubiquitin modification of related proteins in the host NF-κB signaling pathway. Further analysis showed that the ubiquitination levels of NEMO K63 (K63-Ub) and Met1 (Met1-Ub) were significantly increased in the 16 M-UGPase-infected cells compared with that of the 16 M-infected cells, further confirming that the ubiquitination levels of NF-κB signaling-related proteins were regulated by the bacterial UGPase. Besides, the expression level of IκBα was decreased, but the level of p-P65 was significantly increased in the 16 M-UGPase-infected cells compared with that of the 16 M- and mock-infected cells, demonstrating that B. melitensis UGPase can significantly inhibit the degradation of IκBα and the phosphorylation of p65, and thus suppressing the NF-κB pathway.

Conclusions: The results of this study showed that Brucella melitensis UGPase inhibits the activation of NF-κB by modulating the ubiquitination of NEMO, which will provide a new scientific basis for the study of immune mechanisms induced by Brucella.

Citing Articles

CMTM3 protects the gastric epithelial cells from apoptosis and promotes IL-8 by stabilizing NEMO during Helicobacter pylori infection.

Ning J, Fu W, Shi Y, Zhang J, Ding S Gut Pathog. 2023; 15(1):6.

PMID: 36782312 PMC: 9924195. DOI: 10.1186/s13099-023-00533-4.

References

Fiil B, Gyrd-Hansen M . Met1-linked ubiquitination in immune signalling. FEBS J. 2014; 281(19):4337-50. PMC: 4286102. DOI: 10.1111/febs.12944. View

de Figueiredo P, Ficht T, Rice-Ficht A, Rossetti C, Adams L . Pathogenesis and immunobiology of brucellosis: review of Brucella-host interactions. Am J Pathol. 2015; 185(6):1505-17. PMC: 4450313. DOI: 10.1016/j.ajpath.2015.03.003. View

Chen Z . Ubiquitin signalling in the NF-kappaB pathway. Nat Cell Biol. 2005; 7(8):758-65. PMC: 1551980. DOI: 10.1038/ncb0805-758. View

Kato T, Hagiyama M, Takashima Y, Yoneshige A, Ito A . Cell adhesion molecule-1 shedding induces apoptosis of renal epithelial cells and exacerbates human nephropathies. Am J Physiol Renal Physiol. 2017; 314(3):F388-F398. PMC: 6048447. DOI: 10.1152/ajprenal.00385.2017. View

Zhou Y, Bu Z, Qian J, Chen Y, Qiao L, Yang S . The UTP-glucose-1-phosphate uridylyltransferase of Brucella melitensis inhibits the activation of NF-κB via regulating the bacterial type IV secretion system. Int J Biol Macromol. 2020; 164:3098-3104. DOI: 10.1016/j.ijbiomac.2020.08.134. View

Celli J, de Chastellier C, Franchini D, Pizarro-Cerda J, Moreno E, Gorvel J . Brucella evades macrophage killing via VirB-dependent sustained interactions with the endoplasmic reticulum. J Exp Med. 2003; 198(4):545-56. PMC: 2194179. DOI: 10.1084/jem.20030088. View

Chang H, Lee J, Deng W, Fu T, Peng H . Virulence and outer membrane properties of a galU mutant of Klebsiella pneumoniae CG43. Microb Pathog. 1996; 20(5):255-61. DOI: 10.1006/mpat.1996.0024. View

Zhou H, Monack D, Kayagaki N, Wertz I, Yin J, Wolf B . Yersinia virulence factor YopJ acts as a deubiquitinase to inhibit NF-kappa B activation. J Exp Med. 2005; 202(10):1327-32. PMC: 2212976. DOI: 10.1084/jem.20051194. View

Byndloss M, Tsolis R . Brucella spp. Virulence Factors and Immunity. Annu Rev Anim Biosci. 2016; 4:111-27. DOI: 10.1146/annurev-animal-021815-111326. View

10.

Newton K, Dixit V . Signaling in innate immunity and inflammation. Cold Spring Harb Perspect Biol. 2012; 4(3). PMC: 3282411. DOI: 10.1101/cshperspect.a006049. View

11.

Ciani B, Layfield R, Cavey J, Sheppard P, Searle M . Structure of the ubiquitin-associated domain of p62 (SQSTM1) and implications for mutations that cause Paget's disease of bone. J Biol Chem. 2003; 278(39):37409-12. DOI: 10.1074/jbc.M307416200. View

12.

Renaud L, Picher-Martel V, Codron P, Julien J . Key role of UBQLN2 in pathogenesis of amyotrophic lateral sclerosis and frontotemporal dementia. Acta Neuropathol Commun. 2019; 7(1):103. PMC: 6889556. DOI: 10.1186/s40478-019-0758-7. View

13.

Komeda Y, Icho T, Iino T . Effects of galU mutation on flagellar formation in Escherichia coli. J Bacteriol. 1977; 129(2):908-15. PMC: 235029. DOI: 10.1128/jb.129.2.908-915.1977. View

14.

Luo H, Lin Y, Gao F, Zhang C, Zhang R . DEG 10, an update of the database of essential genes that includes both protein-coding genes and noncoding genomic elements. Nucleic Acids Res. 2013; 42(Database issue):D574-80. PMC: 3965060. DOI: 10.1093/nar/gkt1131. View

15.

Berbis M, Sanchez-Puelles J, Canada F, Jimenez-Barbero J . Structure and Function of Prokaryotic UDP-Glucose Pyrophosphorylase, A Drug Target Candidate. Curr Med Chem. 2015; 22(14):1687-97. DOI: 10.2174/0929867322666150114151248. View

16.

Hrdinka M, Fiil B, Zucca M, Leske D, Bagola K, Yabal M . CYLD Limits Lys63- and Met1-Linked Ubiquitin at Receptor Complexes to Regulate Innate Immune Signaling. Cell Rep. 2016; 14(12):2846-58. PMC: 4819907. DOI: 10.1016/j.celrep.2016.02.062. View

17.

Iwasawa R, Mahul-Mellier A, Datler C, Pazarentzos E, Grimm S . Fis1 and Bap31 bridge the mitochondria-ER interface to establish a platform for apoptosis induction. EMBO J. 2010; 30(3):556-68. PMC: 3034017. DOI: 10.1038/emboj.2010.346. View

18.

Kim D, Lenzen G, Page A, Legrain P, Sansonetti P, Parsot C . The Shigella flexneri effector OspG interferes with innate immune responses by targeting ubiquitin-conjugating enzymes. Proc Natl Acad Sci U S A. 2005; 102(39):14046-51. PMC: 1236552. DOI: 10.1073/pnas.0504466102. View

19.

Van Acker T, Eyckerman S, Vande Walle L, Gerlo S, Goethals M, Lamkanfi M . The small GTPase Arf6 is essential for the Tram/Trif pathway in TLR4 signaling. J Biol Chem. 2013; 289(3):1364-76. PMC: 3894321. DOI: 10.1074/jbc.M113.499194. View

20.

Lopez I, Cariolato L, Maric D, Gillet L, Abriel H, Diviani D . A-kinase anchoring protein Lbc coordinates a p38 activating signaling complex controlling compensatory cardiac hypertrophy. Mol Cell Biol. 2013; 33(15):2903-17. PMC: 3719681. DOI: 10.1128/MCB.00031-13. View